Impact of anti-PD-1 therapy in a melanoma patient with paraneoplastic anti-ITPR1 encephalitis

Rev Neurol (Paris). 2024 Mar;180(3):216-217. doi: 10.1016/j.neurol.2023.10.010. Epub 2023 Dec 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autoantibodies
  • Encephalitis* / diagnosis
  • Encephalitis* / drug therapy
  • Humans
  • Melanoma* / complications
  • Melanoma* / drug therapy
  • Paraneoplastic Syndromes*

Substances

  • Autoantibodies